Clinical Trials Sponsored by Dongliang Zhang, MD

Total 57 results

Dongliang Zhang, MD

Terminated

The Outcomes of Arteriovenous Fistula Cannulated From Different Direction.

Arteriovenous Fistula

China
Zhang longjiang,MD

Recruiting

Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population (RESPECT2)

Adherence, Medication | Primary Prevention | Cardiovascular Risk Factors | Statin

China
Dongliang Zhang, MD
Beijing Municipal Science & Technology Commission

Completed

Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder

Vitamin D Deficiency

China
Dongliang Zhang, MD
Beijing Municipal Science & Technology Commission

Completed

Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients

Hyperparathyroidism | Disorders of Parathyroid Gland

China
Dongying Zhang

Recruiting

Role of SGLT2I in Patients With Myocardial Infarction

Myocardial Infarction | Diabetes Mellitus

China
Dongying Zhang

Completed

The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI

ST Elevation Myocardial Infarction
Dongying Zhang

Recruiting

Relationship Between Ambulatory Arterial Stiffness Index and Left Ventricular Diastolic Function in Patients With HFpEF

Heart Failure With Preserved Ejection Fraction

China
Dongying Zhang

Completed

The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF Patients

Heart Failure With Preserved Ejection Fraction

China
Dongying Zhang

Completed

The Eosinophils Percentage Predicts In-hospital Major Adverse Cardiac Events in STEMI Patients After PCI

ST Elevation Myocardial Infarction
Zhang Bi Xiang, MD

Recruiting

Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma (CCGLC-003)

Hyperbaric Oxygen Therapy | Combinational Immunotherapy | Hepatocellular Carcinoma Non-Resectable

China
Li Zhang, MD

Not yet recruiting

Phase III Study Comparing Osimertinib Monotherapy to Combination Therapy With Osimertinib,Carboplatin and Pemetrexed for Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer With Concurrent EGFR and TP53 Mutations (TOP)

Non-small Cell Carcinoma | EGFR Gene Mutation

China
Li Zhang, MD

Recruiting

An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

Small Cell Lung Cancer | Lung Cancer | Durvalumab

China
Li Zhang, MD

Recruiting

Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance (ERSGATR)

The Diagnosis Was ALK Positive NSCLC | Second Generation ALK-TKI is Resistant | Efficacy of Ensatinib in This Subset of Patients

China
Li Zhang, MD

Recruiting

Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

China
Li Zhang, MD

Not yet recruiting

JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.

Non-small Cell Lung Cancer

China
Ting Chang, MD

Not yet recruiting

Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis

Myasthenia Gravis

China
Robert T. Chang, MD

Recruiting

Swept Source OCT Imaging With the DREAM VG-OCT

Glaucoma | Eye Diseases | Myopia

United States
Shuguo Zheng, MD

Recruiting

Laparoscope Anatomical and Aon-anatomical Hepatectomy

Hepatocellular Carcinoma

China
Shuguo Zheng, MD

Unknown

Classical Procedure Versus Intrahepatic Glisson's Approach (LAHIGA)

Liver Diseases | Liver Neoplasms | Hepatic Haemangioma

China
Shuguo Zheng, MD

Unknown

Research of the Key Technology and Standardization of Minimal Invasive Treatment for Hepatolithiasis

Biliary Stones

China
Shuguo Zheng, MD

Recruiting

Laparoscopic Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy

Liver Tumor

China
Shuguo Zheng, MD

Completed

Laparoscopic Hepatectomy Versus Open Hepatectomy for PHC

Primary Liver Carcinoma

China
Zhang Xiaofeng,MD

Completed

Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation in Low-risk Patients

Colonic Neoplasms

China
Zhang Xiaofeng,MD

Active, not recruiting

A RCT of the Efficacy of Tegoprazan 50mg QD in the Treatment of Helicobacter Pylori Infection ( TATH-1 ) (TATH-1)

Helicobacter Pylori Infection | Proton Pump Inhibitor | Vonoprazan

China
Xianwei Zhang，MD

Recruiting

Correlation Between Thermal Patterns of Infrared Thermal Imaging and Clinical Phenotype in Patients With Postherpetic Neuralgia

Postherpetic Neuralgia | Infrared Thermal Imaging

China
John Chang, MD

Unknown

An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer (Clarity)

Prostate Adenocarcinoma

United States
Jun Zhang, MD, PhD

Recruiting

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

NSCLC Stage IV | NSCLC, Recurrent

United States
Zhang Lei, MD

Recruiting

Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia

Thrombocytopenia | Antiphospholipid Syndrome | Treatment

China
Hongqi Zhang, MD
Beijing Haidian Hospital

Recruiting

Clinical Outcome in Patients With Spinal Dural Arteriovenous Fistulas (COPSDAVF) (COPSDAVF)

Spinal Vascular Disorder Nos

China
Zhang Qi, MD

Unknown

Risk Factors Promoting Coronary Plaque Progression In China (RIPPER)

Coronary Artery Disease

China
Yong Zhang,MD

Recruiting

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer

Rectal Neoplasms

China
Yong Zhang,MD

Recruiting

Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Uterine Cervical Neoplasms

China
Yong Zhang,MD

Unknown

Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma (ECWHCCFLACC)

Cervical Carcinoma

China
Zhang Qi, MD

Unknown

Sequential Therapy of Atorvastatin Improve Outcomes of ST-elevated Acute Myocardial Infarction

Acute Myocardial Infarction

China
Chun-Hua Wang, MD

Unknown

Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis

Bronchiectasis Adult | Osteoporosis, Osteopenia

Taiwan
Kiyuk Chang, MD,PhD

Recruiting

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI (ROSUZET-AMI)

Myocardial Infarction | Statin Adverse Reaction | HMG-CoA Reductase Inhibitor Toxicity

Korea, Republic of
Jun Zhang, MD, PhD
Nilogen Oncosystems

Recruiting

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC (TUMORIN)

NSCLC | Lung Cancer | NSCLC Stage IV

United States
Jenny C. Chang, MD
The Methodist Hospital Research Institute

Completed

T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer (STELA)

Metastatic Breast Cancer

United States
Trina E. Chang, MD
Dupont-Warren

Completed

Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority Patients

Major Depressive Disorder

United States
Zheng-Yu Hoe, MD., PhD.

Recruiting

Effects of Extracorporeal Shock Wave Therapy and Pulse Electromagnetic Field Therapy on Lymphoedema

Lymphedema

Taiwan
Jenny C. Chang, MD
The Methodist Hospital Research Institute

Completed

NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer (NECTAR)

Breast Cancer | Triple Negative Breast Cancer

United States
Zhang Xiaofeng,MD
Zeno Therapeutics Pte. Ltd

Not yet recruiting

Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer

Pancreatic Cancer | Advanced Biliary Cancer
Jun Zhang, MD, PhD
Genentech, Inc.; Exelixis

Not yet recruiting

A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) (Cabatezo-1)

Lung Cancer | NSCLC Stage IV | Advanced NSCLC | Metastatic NSCLC - Non-Small Cell Lung Cancer

United States
Jun Zhang, MD, PhD
Rhode Island Hospital

Recruiting

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients (Microdurva)

NSCLC, Stage III | Locally Advanced Lung Carcinoma

United States
Jenny C. Chang, MD
GE Healthcare; The Methodist Hospital Research Institute

Withdrawn

PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

Breast Cancer

United States
Jenny C. Chang, MD
Genentech, Inc.; The Methodist Hospital Research Institute

Withdrawn

Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast Cancer (NATURE)

Breast Cancer

United States
Jun Zhang, MD, PhD
University of Iowa; University of Kentucky

Recruiting

Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy (Ipat-Lung)

NSCLC Stage IV | NSCLC Stage IIIB

United States
Yunling Zhang
Shandong University of Traditional Chinese Medicine; Huairou Hospital of Traditional...

Unknown

Heat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction

Ischemic Stroke

China
Yunling Zhang
Shandong University of Traditional Chinese Medicine; Huairou Hospital of Traditional...

Completed

Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations

Ischemic Stroke

China
Yan Zhang, MD
Peking University First Hospital; Chinese PLA General Hospital; Peking University...

Recruiting

Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients

Diffuse Large B Cell Lymphoma

China

Clinical Trials Sponsored by Dongliang Zhang, MD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations